Encompass Health Corporation
EHC
$98.09
$1.972.05%
NYSE
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | 455.70M | 422.40M | 399.50M | 376.80M | 352.00M |
Total Depreciation and Amortization | 299.60M | 291.70M | 280.60M | 280.30M | 273.90M |
Total Amortization of Deferred Charges | 9.70M | 9.50M | 9.50M | 9.50M | 9.50M |
Total Other Non-Cash Items | 215.90M | 190.90M | 187.30M | 184.30M | 165.10M |
Change in Net Operating Assets | 21.90M | 10.50M | -4.50M | 10.80M | 50.30M |
Cash from Operations | 1.00B | 925.00M | 872.40M | 861.70M | 850.80M |
Capital Expenditure | -642.50M | -655.50M | -657.70M | -622.70M | -583.10M |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -10.80M | -2.20M | -700.00K | -5.80M | -19.70M |
Cash from Investing | -653.30M | -657.70M | -658.40M | -628.50M | -602.80M |
Total Debt Issued | 95.00M | 65.00M | 50.00M | 100.00M | 80.00M |
Total Debt Repaid | -337.00M | -225.70M | -96.20M | -168.70M | -163.30M |
Issuance of Common Stock | -- | -- | -- | -- | -- |
Repurchase of Common Stock | -43.20M | -35.80M | -29.40M | -12.60M | -8.20M |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -62.80M | -60.70M | -60.70M | -60.70M | -60.40M |
Other Financing Activities | 17.40M | 47.60M | -49.60M | -37.80M | -45.30M |
Cash from Financing | -330.60M | -209.60M | -185.90M | -179.80M | -197.20M |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 18.90M | 57.70M | 28.10M | 53.40M | 50.80M |